Main Page

HemOnc.org - A Free Hematology/Oncology Reference

4,428 regimens on HemOnc.org

6,544 variants on HemOnc.org

Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.

Mobile/tablet version of the main page
Browse our complete index of pages

Quick links to chemotherapy regimens
Solid tumors
Anal cancer	Bladder cancer	Bone cancer	Breast cancer
Central nervous system (CNS) cancer	Cervical cancer	Colon cancer	Esophageal cancer
Gastric cancer	Head and neck cancer	Hepatobiliary cancer	Lung cancer, non-small cell
Lung cancer, small cell	Melanoma	Mesothelioma	Neuroendocrine tumors
Skin, basal & squamous cancer	Ovarian cancer	Pancreatic cancer	Penile cancer
Prostate cancer	Rectal cancer	Renal cancer	Sarcoma
Testicular cancer	Thymoma	Thyroid cancer	Unknown primary
Uterine cancer
Acute leukemias
Acute lymphocytic leukemia (ALL)	Acute myeloid leukemia (AML)	Acute promyelocytic leukemia (APL)	Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML)	Chronic myelomonocytic leukemia (CMML)	Essential thrombocythemia (ET)	Hypereosinophilic syndrome (HES)
Mast cell diseases	Myelodysplastic syndrome	Primary & secondary myelofibrosis	Polycythemia vera (PV)
Mature B-, T-, and NK-cell neoplasms
Anaplastic large cell lymphoma (ALCL)	Burkitt lymphoma (BL) or Burkitt-like lymphoma	Chronic lymphocytic leukemia (CLL/SLL)	CNS lymphoma
Cutaneous T-cell lymphoma (CTCL)	Diffuse large B-cell lymphoma (DLBCL)	Extranodal NK/T-cell lymphoma, nasal type	Follicular lymphoma (FL)
Hairy cell leukemia (HCL)	HIV-associated lymphoma	Hodgkin lymphoma (HL)	Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Large granular lymphocytic (LGL) leukemia	Light-chain (AL) amyloidosis	Mantle cell lymphoma (MCL)	Marginal zone lymphoma (MZL)
Mediastinal gray-zone lymphoma (MGZL)	Multiple myeloma (MM)	NK/T-cell lymphoma	Peripheral T-cell Lymphoma (PTCL)
Primary mediastinal B-cell lymphoma (PMBL)	Transformed lymphoma (TL)	Transplant conditioning regimens	Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia	Autoimmune thrombocytopenic purpura (ITP)	Castleman’s disease	Coagulopathies
Paroxysmal nocturnal hemoglobinuria (PNH)	Venous thromboembolism (VTE)

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

1. Creating a database of chemotherapy agents and other medications.
2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
3. Sample order sets and examples of supportive medications used with treatment regimens
4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

1. Creating summaries of pivotal clinical trials
2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
3. Checklists for common clinical scenarios/diseases
4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.

If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.